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Background: Recent studies indicate that maternal exposure to ambient ultrafine particles and nanoparticles has
adverse effects of on the central nervous system. Quantitative dose–response data is required to better understand
the developmental neurotoxicity of nanoparticles. The present study investigated dose-dependent effects of maternal
exposure to carbon black nanoparticle (CB-NP) on astrocyte in the brains of mouse offspring.
Methods: A CB-NP suspension (2.9, 15, or 73 μg/kg) was intranasally administered to pregnant ICR mice on gestational
days 5 and 9. Cerebral cortex samples were collected from 6-week-old offspring and examined by Western blotting,
immunostaining, microarray analysis, and quantitative reverse transcriptase-polymerase chain reaction. Placentae were
collected from pregnant dams on gestational day 13 and examined by microarray analysis.
Results: Maternal exposure to CB-NP induced a dose-dependent increase in glial fibrillary acidic protein (GFAP)
expression in the cerebral cortex; this increase was particularly observed in astrocytic end-feet attached to denatured
perivascular macrophages. Moreover, maternal CB-NP exposure dose-dependently increased aquaporin-4 expression in
the brain parenchyma region around blood vessels. The changes in the expression profiles of GFAP and Aqp4 in offspring
after maternal CB-NP exposure were similar to those observed in mice of a more advanced age. The expression levels of
mRNAs associated with angiogenesis, cell migration, proliferation, chemotaxis, and growth factor production were also
altered in the cerebral cortex of offspring after maternal CB-NP exposure. Differentially expressed genes in placental
tissues after CB-NP exposure did not populate any specific gene ontology category.
Conclusions: Maternal CB-NP exposure induced long-term activation of astrocytes resulting in reactive astrogliosis in the
brains of young mice. Our observations suggest a potentially increased risk of the onset of age-related neurodegenerative
diseases by maternal NP exposure. In this study, we report for the first time a quantitative dose–response relationship
between maternal NP exposure and phenotypic changes in the central nervous system of the offspring. Moreover, our
findings indicate that cortical GFAP and Aqp4 are useful biomarkers that can be employed in further studies aiming to
elucidate the underlying mechanism of nanoparticle-mediated developmental neurotoxicity.
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The development of nanotechnology provides several
benefits to the global market, but is also accompanied by
new potential health risks through occupational and
environmental nanoparticles (NPs) exposure [1]. The
safe handling and use of NPs first requires an under-
standing of the mechanism underlying NP exposure tox-
icity. Developmental and reproductive studies are widely
recognized as important parts of toxicological science.
In particular, various industrial chemicals are known to
directly and indirectly affect the central nervous system
during vulnerable stages of development [2, 3]. Clinical
cohort and animal studies have revealed that prenatal
exposure to particulate air pollution including black car-
bon is associated with an increased risk of brain devel-
opmental disorders such as autism spectrum disorder
and schizophrenia in offspring [4–6]. However, informa-
tion about the toxic effects of maternal NP exposure in
developmental and reproductive toxicity studies remains
limited [7–9]. In particular, few experimental animal
studies have investigated the effects of prenatal exposure
to carbon-based NPs on the developing central nervous
systems of offspring [7, 8]. Therefore, the goal of the
present study was to provide information on the devel-
opmental neurotoxicity of maternal exposure to carbon
black nanoparticle (CB-NP).
Quantitative dose–response data is required for under-
standing developmental neurotoxicity. The US Environ-
mental Protection Agency has indicated that dose–
response data could help to reduce critical gaps in the
current understanding of NP-associated developmental
neurotoxicity [10]. However, only one in vivo study has
reported the neurodevelopmental effects of NPs using
multiple doses, and no dose–response relationship was
observed in that study [11]. Additional quantitative
dose–response studies evaluating maternal exposure to
NPs are necessary to facilitate the risk assessment and
hazard identification of NPs.
Previous studies have shown that maternal CB-NP
exposure had adverse effects on the liver and brain of
the offspring [11, 12]. While these studies have provided
interesting insights, the sensitive target regions, affected
cell types, and biomolecules in the brain remained to be
elucidated. Our previous study demonstrated that mater-
nal CB-NP exposure induced long-lasting diffuse peri-
vascular abnormalities including histopathological
changes in perivascular macrophages, the up-regulation
of glial fibrillary acidic protein (GFAP) in astrocytes, and
swollen astrocytic end-feet in the cerebral cortex [13].
The swelling of astrocytic end-feet related to maternal
CB-NP exposure may be caused by changes in water
transportation and ion homeostasis, which are notably
regulated by aquaporin-4 (Aqp4) [14]. Hence, GFAP and
Aqp4 may serve as quantitative and sensitive endpointsfor the investigation of dose-dependent developmental
toxicity after NP exposure, and increase knowledge on
the mechanisms underlying subsequent neurobehavioral
changes. Therefore, the present study investigated dose-
dependent and long-term effects of maternal CB-NP ex-
posure on astrocyte in the cerebral cortex of offspring
mice. We used Western blotting to provide information
on the dose-dependency of effects on GFAP and Aqp4
protein expression in astrocytes, immunostaining to elu-
cidate the localization of these proteins in the cerebral
cortex, and microarray as well as quantitative reverse
transcription-polymerase chain reaction (qRT-PCR) ana-
lyses to examine comprehensive changes in gene expres-




Printex 90 NP (Degussa Ltd., Frankfurt, Germany) were
used for the CB-NP suspension. According to the manu-
facturer, the average primary particle size of Printex 90
NP is 14 nm, with a specific surface area of approxi-
mately 300 m2/g and an organic impurity content of less
than 1% [12].
Printex 90 NP were suspended at a concentration of
2 mg/mL in ultra-pure water (10 mL), sonicated for
20 min using an ultrasonic cleaner, and immediately in-
cubated on ice for 20 min. The intermediate phase
(4 mL) was subjected to centrifugation at 16,000 × g for
20 min at 4 °C to remove bulk agglomeration. Finally,
2 mL of the supernatant suspension was collected and
administered to mice in the high-dose (73 μg/kg) group.
The suspension was diluted 5-fold and 25-fold with
ultra-pure water for administration to the middle-dose
(15 μg/kg) and low-dose (2.9 μg/kg) groups, respectively.
The size of secondary CB-NP in suspensions was char-
acterized by transmission electron microscope (TEM;
JEM 1200EXII, JEOL Ltd., Akishima, Tokyo, Japan)
(irradiation current, 56 μA; acceleration voltage, 80 kV)
on collodion-coated 200 Cu mesh (cat no. 6511, Nisshin
EM Co. Ltd., Tokyo, Japan) and dynamic light scatter-
ing measurements using a NANO-ZS (Sysmex Co.,
Hyogo, Japan).
To determine the concentration of CB-NP in the each
suspension, suspensions for administrations and stand-
ard suspensions (31.3, 62.5, 125 μg/mL) were concen-
trated from 1000 μL to 20 μL with a heating vaccum
concentrator (MV-100, Tomy Seiko Co. Ltd., Tokyo,
Japan), and 1 μL of each sample was dropped onto mo-
lybdenum single-hole sheet mesh (cat no. 09–1035,
0.3 mm, Okenshoji Co. Ltd., Tokyo, Japan), air-dried,
and subjected to energy-dispersive X-ray spectrometry
(EDX) under field emission-scanning electron micro-
scope (FE-SEM; JSM-6500 F, JEOL Ltd., Tokyo, Japan)
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concentrations were calculated from the reduction of
peak areas of molybdenum signal (2.290 keV) masked by
carbon particles.
Animals and treatments
Forty pregnant ICR mice (11 weeks of age) that were
free of pathogens were purchased from SLC Inc. (Shizu-
oka, Japan), and housed separately in standard plastic
cages. The animals were randomly allocated to one of
four groups (n = 10/group; a control group, a low-dose
group, a middle-dose group, and a high-dose group;
Fig. 1a,b) and housed under pathogen-limited conditions
with controlled temperature (22–24 °C) and relative
humidity (50–60%) on a 12-h light/dark cycle with food
and water available ad libitum. Animals were then ran-
domly assigned to brain and placenta experiments. Preg-
nant mice were anesthetized with halothane, laid ventral
side-up, and intranasally administered 1 mL/kg of CB-
NP suspension (2.9, 15, 73 μg/mL) or ultra-pure water
(0 μg/mL) into both nostrils. The treatments were per-
formed on gestational days 5 and 9, as murine fetuses
are particularly sensitive to various foreign substances
during early gestation compared to any other fetal
period [15, 16]. Placentae were collected from pregnant
mice (n = 5/group) on GD13 (Fig. 1a). On postnatal day
1, the number of pups per dam was adjusted randomly
to 11 or 12. Four male offspring mice per dam wereFig. 1 Summarized scheme of animal treatments and sample collectionrandomly selected after weaning at three weeks of age,
and brains were collected from these offspring mice at
6 weeks after birth (Fig. 1b) in order to assign randomly
to (1) protein expression analysis by western blotting, (2)
double-staining for GFAP and periodic acid Schiff (PAS)
staining, (3) double-immunofluorescence staining for
GFAP and Aqp4, and (4) gene expression analysis by
microarray and qRT-PCR (Fig. 1b; one pup per litter for
each outcome).
All experiments were performed in accordance with
Animal Research: Reporting in vivo Experimental Guide-
lines for the Care and Use of Laboratory Animals [17]
and were approved by the Tokyo University of Science
Institutional Animal Care and Use Committee. All tissue
sampling was performed under anesthesia with sodium
pentobarbital (70 mg/kg, intraperitoneal) and all efforts
were made to minimize pain and suffering.
Protein extraction
Dissected cerebral cortices (Fig. 2) from 6-week-old male
offspring (n = 5/group) were homogenized using the Bio-
masher II and Powermasher (Nippi Inc., Tokyo, Japan)
in T-PER Tissue Protein Extraction Reagent (20 mL/g of
tissue) (Takara Bio. Inc., Shiga, Japan) containing prote-
ase inhibitor cocktail (Complete tablet, EDTA-free,
Roche Diagnostics, Basel, Switzerland) at 4 °C. Homoge-
nates were centrifuged at 10,000 × g for 5 min at 4 °C to
remove insoluble debris and then supernatants were
Fig. 2 Collected/analyzed areas of the cerebral cortex in offspring mice (red zone)
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trations were determined by the bicinchoninic acid
method using the Pierce BCA Protein Assay kit
(Thermo Fisher Scientific K.K., MA, USA). Extracts were
then stored at −80 °C until use.
SDS-PAGE and western blotting
Protein extracts were mixed with denaturing sample buf-
fer (125 mM Tris–HCl [pH 6.8], 20% glycerol, 4% w/v
sodium dodecyl sulfate [SDS], 0.001% w/v bromophenol
blue and 10% mercaptoethanol) and denatured by heat-
ing for 5 min at 95 °C. For each sample, 25 μg of protein
per lane was loaded onto a 10% SDS-polyacrylamide gel,
and electrophoresed initially at 110 V for 30 min at
room temperature and subsequently at 150 V for
110 min at 4 °C. Separated proteins were electroblotted
onto a polyvinylidene difluoride membrane (Merck
Millipore, MA, USA) for 1 h at 400 mA at room
temperature. After blocking with 5% skim milk in Tris-
buffered saline (pH 7.4) containing 0.1% Tween-20
(TBS-T), membranes were incubated with primaryrabbit polyclonal anti-GFAP antibody (code-no. Z0334,
Dako Cytomation, Copenhagen, Denmark; 1:1000),
rabbit monoclonal anti-β-actin (13E5) antibody (code-
no. 4970, Cell Signaling Technology, Inc., MA, USA;
1:2000), or rabbit polyclonal anti-Aqp4 antibody (code-
no. AB3594, Merck Millipore; 1:200) overnight at 4 °C
followed by incubation with secondary horseradish per-
oxidase (HRP)-conjugated anti-rabbit IgG (code-no. sc-
2004, Santa Cruz Biotechnology, Inc., Santa Cruz, CA,
USA; 1:10000 for β-actin; 1:5000 for GFAP and Aqp4)
for 1 h at room temperature. Between each step, immu-
noblots were washed thoroughly with TBS-T. Secondary
antibody binding was visualized by chemiluminescence
with Immobilon Westem Chemiluminescent HRP Sub-
strate (Merck Millipore). To quantify detected signals,
images were scanned using a ChemiDoc MP System
(Bio-Rad Laboratories, Inc., TX, USA) and analyzed
using Image Lab software (Bio-Rad Laboratories). Mouse
GFAP molecules appeared at 55 kDa, corresponding to
this molecule, on SDS-PAGE and also at 48 kDa (a
GFAP-derived band). The densities of bands for GFAP
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were quantified with background subtraction, and values
for GFAP and Aqp4 were corrected to the correspond-
ing value of β-actin in each sample.
Double-staining for GFAP and periodic acid Schiff (PAS)
staining-positive granules
Brains from 6-week-old male offspring mice (n = 5/
group) were used for double-staining of GFAP and PAS-
positive granules. Anesthetized mice were transcardially
perfused with phosphate-buffered saline (PBS) and sub-
sequently fixed by perfusion with 4% paraformaldehyde
(PFA) in 0.1 M phosphate buffer. Brain samples were
then post-fixed in 4% PFA in 0.1 M phosphate buffer for
24 h. Brains were embedded in paraffin and cut into 6-
μm sagittal sections. Visualization of GFAP and PAS-
positive granules was performed on paraffin sections
using the appropriate antibodies and an avidin–biotin-
peroxidase method. After blocking endogenous peroxid-
ase by preincubation with 10% normal horse serum,
sections were incubated in primary rabbit polyclonal
anti-GFAP antibody (code-no. Z0334, DakoCytomation)
diluted 1:1000 in PBS containing 0.1% Trion X (PBS-Tx)
for 16 h at 4 °C. After rinsing 3 times for 5 min per rinse
with PBS-Tx, sections were further incubated in second-
ary biotinylated donkey anti-rabbit IgG (code-no.
AP182B, Chemicon, Temecula, CA, USA; 1:1000) for
120 min at room temperature and rinsed 3 times for
5 min per rinse with PBS-Tx. Sections were then treated
with 1% periodic acid solution for 3 min, rinsed with
distilled water for 1 min, and soaked in cold Schiff re-
agent for 60 min. Next, sections were soaked in sulfur-
ous acid solution 3 times for 3 min per soak and then
rinsed with distilled water for 1 min. Finally, sections
were treated with an avidin-biotin-peroxidase complex
(Vectastain ABC peroxidase kit, Vector Laboratories
Inc., CA, USA; 1:400) for 120 min and reacted in a solu-
tion of 0.02% 3,3′-diaminobenzidine (DAB) in 0.1 M
Tris–HCl buffer (pH 7.6) and 0.01% H2O2 for 20 min to
detect peroxidase activity. GFAP immunoreactivity local-
ized to the astrocytic cytoplasm was visible as light-
brown staining. Sections were then washed in PBS,
dehydrated in graded alcohol, cleared in xylene, and cov-
erslips were applied with permount mounting medium
(Thermo Fisher Scientific). Fifty sections (total 300 μm)
from the longitudinal fissure of the cerebrum along sa-
gittal plane were prepared from each mouse. One in
every 5 sections was chosen (every 30 μm), and totally
10 sections per one mouse were subjected for PAS-
GFAP staining analysis.
Double-immunofluorescence staining for GFAP and Aqp4
Brains from 6-week-old (n = 5/group) male offspring
mice and normally aged mice (as a positive control)were used for double-immunofluorescence staining of
GFAP and Aqp4. Anesthetized mice were transcardially
perfused with PBS and subsequently fixed with 4% PFA
in 0.1 M phosphate buffer. Coronal sections (1 mm) of
brains were post-fixed in 4% PFA in 0.1 M phosphate
buffer for 5 h, cryoprotected in phosphate-buffered
sucrose (10% sucrose, 4–6 h; 20% sucrose, 4–6 h; and
30% sucrose, 12–36 h) with 0.1% sodium azide,
embedded in Tissue-Tek OCT compound (Sakura
Finetek Japan Co., Ltd., Tokyo, Japan), frozen, and
then cut into 10-μm sections.
Immunofluorescence was used to evaluate protein ex-
pression patterns of Aqp4 and GFAP in brain sections.
Sections were blocked with 10% normal horse serum for
1 h at room temperature and then incubated with pri-
mary goat polyclonal anti-GFAP antibody (code-no.
ab53554, Abcam, Cambridge, UK; 1:500) diluted 1:1000
in PBS for 16 h at 4 °C. After rinsing 3 times for 5 min
per rinse with PBS, sections were further incubated with
secondary Dylight 488-conjugated donkey anti-goat IgG
(code-no. 605-741-125, Rockland Immunochemicals
Inc., PA, USA; 1:1000) for 120 min at room temperature
and rinsed 3 times for 5 min per rinse with PBS. Sec-
tions were further incubated with primary rabbit poly-
clonal anti-Aqp4 antibody (code-no. AB3594, Merck
Millipore; 1:100) diluted 1:1000 in PBS for 16 h at 4 °C.
After rinsing 3 times for 5 min per rinse with PBS,
sections were then incubated with secondary Dylight
649-conjugated donkey anti-rabbit IgG (code-no. 611-
743-127, Rockland Immunochemicals Inc; 1:1000) for
120 min at room temperature, rinsed 3 times for 5 min
per rinse with PBS and twice for 5 min per rinse with
distilled water, and nuclei were counter-stained with
Hoechst 33342 (code-no. 346–07951, Dojindo Labora-
tories, Kumamoto, Japan). Thirty sections (total 300 μm)
from the longitudinal fissure of the cerebrum along sa-
gittal plane were prepared from each mouse. One in
every 3 sections was chosen (every 30 μm), and totally
10 sections per one mouse were subjected for this im-
munofluorescence analysis.
Line profiling of immunofluorescence in stained sections
Aqp4 expression in the cerebral cortex was further eval-
uated by fluorescence microscopy (Biorevo BZ-9000,
Keyence Corporation, Osaka, Japan) of immunostained
sections. Quantification was performed as per a previous
study that detected changes in the expression level of
GFAP and Aqp4 around blood vessels in the cerebral
cortex [18]. The fluorescent intensity profile of Aqp4
was captured on a line that was set over a blood vessel
40-μm far from the vessel wall on either side into the
surrounding brain tissue, and quantified with line
profiling software (BZ-H2C, Dynamic Cell Count
Vers.1.1, Keyence).
Table 1 Primer and probe sequences for quantitative reverse
transcription-polymerase chain reaction analyses
Gene Sequence (5′–3′) Tm
(°C)
Gapdh (NM_008084.2) F TGTGCAGTGCCAGCCTCGTC 60
R GGATGCATTGCTGACAATCT
Sox17 (NM_011441) F AAGTAGCTCCAGAAACTGCAG 60
R CTGCTCATTGTATCCATGAGGTGA
Tgfa (NM_031199) F CTAGCGCTGGGTATCCTG 60
R CACTCACAGTGTTTGCGGAG
Nos3 (NM_008713) F CTCTGCCTCACTCATGGGCACG 60
R GGATTTTGTAGCTCTTGTGCTGCTC
Tbx1 (NM_001285472) F CTACCAGAATCACCGGATCACG 60
R CCGAGAGCGAGCAAAGGC
P TAAGATTGCCAGCAACCCCTTCGCCAAAG
Kdr (NM_010612) F TCACCGGAAATCTGGAGAATCAG 60
R CTCAGTACAATGCCTGAATCTTCTAC
P ACAACCATTGGCGAGACCATTGAAGTGACT
Flt1 (NM_010228) F TGAGGAGCTTTCACCGAACTC 60
R ACTCGCTATTCTCAAGTCTATCTTCA
P CTTGGTCTCAGTCCAGGTGAACCGCTTC
Tie1 (NM_011587) F CCATGCTTTTGTCTACCAAAGTCA 60
R GCGGCATTCCCAGAACCC
P AGCCAGACAGGACCACAGCAGAGTT
Cyr61 (NM_010516) F ATCGCAATTGGAAAAGGCAGC 60
R GGCGTGCAGAGGGTTGAAA
P AGGCTTCCTGTCTTTGGCACCGAACC
Cxcl12 (NM_021704) F TCGCCAGAGCCAACGTCAA 60
R GATCCACTTTAATTTCGGGTCAATGC
P CCAAACTGTGCCCTTCAGATTGTTGCACGG
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Dissected cerebral cortex and placenta tissues (n = 5/
group) were homogenized in Isogen solution (Nippon
Gene Co., Ltd., Tokyo, Japan). Total RNA was isolated
with chloroform, purified with isopropanol, and pre-
cipitated in 70% ethanol according to manufacturer
instructions, and finally dissolved in RNase-free
water. RNA concentrations were determined by
spectrophotometry at OD260 using a BioPhotometer
Plus (Eppendorf, Hamburg, Germany). Extracted
RNA from each sample was used for microarray and
quantitative reverse transcription-polymerase chain
reaction (qRT-PCR) analyses.
Microarray analysis
After RNA purification by ethanol precipitation and
using an RNeasy Micro Kit (Qiagen, Hilden, Germany),
the integrity of extracted RNA was evaluated by capillary
electrophoresis using a Bioanalyzer 2100 (Agilent Tech-
nologies, Inc., CA, USA). Total RNAs from 2–3 mice
were pooled within each group. Each pooled RNA sam-
ple (n = 2/group) was labeled by Cy3 and hybridized to a
SurePrint G3 Mouse GE 8x60K microarray (Agilent
Technologies) according to a Takara Bio, Inc. protocol.
The microarray was then washed using a Gene Expres-
sion Wash Buffers Pack (Agilent Technologies) and
scanned with a DNA microarray scanner G2565CA
(Agilent Technologies). Scanner output images were
normalized and digitized using Agilent Feature Extrac-
tion software according to the Minimum Information
About a Microarray Experiment (MIAME) guidelines
[19] and a pre-processing method for Agilent data [20].
Expression threshold levels were set at > two-fold and <
0.5-fold in the high-dose group/control group compari-
son, with a correlation coefficient between nanoparticle
concentration and gene expression of > 0.7 or < −0.7 in
order to identify genes that exhibited dose-dependent
changes in expression.
Functional analysis of microarray data with gene
ontology (GO)
To better understand the biological significance of the
microarray results, a functional analysis was performed
using gene annotation by GO. Genes were annotated
with GO using an annotation file (gene2go.gz) provided
by the National Center for Biotechnology Information
(NCBI; MD, USA). The annotations used were last up-
dated on June 20, 2015. Enrichment factors for each GO
were defined as (nf/n)/(Nf/N), where nf is the number of
flagged (differentially expressed) genes within a given
category, Nf is the total number of genes within that
same category, n is the number of flagged genes on the
entire microarray, and N is the total number of genes on
the microarray. GO with enrichment factors ≥ 2, nf ≥ 3and p < 0.01 were extracted by Fisher’s exact test based
on a hypergeometric distribution.qRT-PCR
Total RNA (1 μg) for each sample was used as a tem-
plate to make the first strand of complementary DNA
(cDNA) using M-MLV Reverse Transcriptase (Invitrogen
Co., Carlsbad, CA, USA) according to manufacturer
specifications. RT-PCR was performed using the SYBR
Green Real-Time PCR Master Mix (Toyobo Co. Ltd.,
Osaka, Japan) and primers (Fasmac Co., Ltd. Kanagawa,
Japan) or Real-Time PCR Master Mix (Toyobo) and
TaqMan primer/probe sets (Applied Biosystems Japan,
Tokyo, Japan) for the indicated genes. We selected 9
genes based on level of expression and plausible role in
pathology from the GO analysis of microarray data. Pri-
mer and probe sequences are shown in Table 1. The
values of target genes were normalized to the expression
level of the housekeeping gene GAPDH.
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All data are expressed as the mean ± SD. Numbers and
sex ratios of pups at birth, offspring body weights at
6 weeks of age, protein expression levels, and mRNA ex-
pression levels were analyzed using a one-way ANOVA
followed by Dunnett post hoc tests. Between-group dif-
ferences in perivascular Aqp4-immunofluorescence were
evaluated using unpaired t-tests. The level of significance
was set at p < 0.05. Statistical analyses were carried out
using Excel Statistics 2012 (Social Survey Research Infor-
mation, Tokyo, Japan).
Results
Characterization of CB-NP suspensions
DLS, TEM, and SEM/EDX were used to characterize
CB-NP suspensions. DLS showed a major peak at
91.0 nm and a minor peak at 840 nm indicating the sec-
ondary diameter of CB-NP in administered suspensions
(Fig. 3a). The 91.0-nm peak corresponded well with the
typical size of small agglomerates of CB-NP observed
under TEM. TEM analysis of the CB-NP suspensions
showed that CB-NP consisted of open chain-
agglomerates of 50–250 nm in diameter (Fig. 3b). The
concentration of each CB-NP suspension for the high-
dose group was 73 μg/mL, as shown by energy-
dispersive X-ray intensity obtained using SEM/EDX;
therefore the concentrations of 5- and 25-fold diluted
suspensions were assumed to be 15 μg/mL and 2.9 μg/
mL, respectively.
Litter sizes and offspring body weights
There were no significant between-group differences in
number or sex ratio of offspring litters at birth (Table 2)
or offspring body weights at 6 weeks of age (Table 3).
GFAP expression levels in the cerebral cortex
Western blotting was conducted to evaluate the expres-
sion level of GFAP in the cerebral cortices of offspring
after maternal CB-NP exposure (Fig. 4a,b). A one-wayFig. 3 Characterization of carbon black nanoparticle (CB-NP) suspensions. a Tra
The yellow numerical value indicates the minor axis - major axis of secondary CB
suspension after centrifugation. Scale bars represent 80 nmANOVA showed a significant effect of CB-NP maternal
treatment (F3, 16 = 17.46, p < 0.001). Post hoc Dunnett
tests showed that GFAP protein expression was signifi-
cantly (**p < 0.01) increased in the middle-dose and
high-dose groups relative to the control group (Fig. 4b).
While GFAP expression in the cerebral cortex generally
increases with age [21], GFAP expression in 6-week-old
mice in the high-dose group was similar to that in mice
of a more advanced age (24-week-old) (Fig. 4b).
Next, PAS-GFAP double staining was performed to
identify the localization of GFAP. Few GFAP-positive as-
trocytes were observed in the cerebral cortices of mice
from the control group (Fig. 4c,d) and those in the low-
dose group (Fig. 4e,f ). In contrast, a large number of
GFAP-positive astrocytes was detected in the cerebral
cortices of mice from the middle-dose and high-dose
groups (Fig. 4g-m). In particular, GFAP expression was
remarkable in areas surrounding blood vessels (Fig. 4j,m).
GFAP-positive astrocytic end-feet were also observed
attached to perivascular macrophages with enlarged
PAS-positive granules (Fig. 4g).Aqp4 expression in the cerebral cortex
Western blotting were carried out to investigate the ex-
pression levels of Aqp4 in the cerebral cortices of off-
spring after maternal CB-NP exposure (Fig. 5a,b)
because Aqp4 is also one of the important molecules for
the function of astrocytes and blood–brain barrier. Aqp4
expression was dose-dependently increased in the cere-
bral cortex in response to maternal CB-NP exposure,
similar to the effect observed on GFAP expression. A
one-way ANOVA showed a significant effect of CB-NP
maternal treatment (F3, 16 = 6.95, p < 0.01). Post hoc
Dunnett tests showed that Aqp4 protein expression was
significantly (*p < 0.05) increased in the high-dose group
relative to the control group (Fig. 5b). While Aqp4 ex-
pression in the cerebral cortex also generally increases
with age [22], Aqp4 expression in 6-week-old mice fromnsmission electron microscopy images of the high-dose CB-NP suspension.
-NP particles. b Dynamic light scattering data of the high-dose CB-NP
Table 2 Effects of maternal exposure to carbon black
nanoparticle on litter size and offspring sex ratio





Control (Ultra-pure water) 5 16 ± 2 47 ± 16
Low-dose CB-NP
(2.9 μg/kg)
5 15 ± 2 44 ± 9
Middle dose CB-NP
(15 μg/kg)
5 14 ± 2 42 ± 9
High dose CB-NP
(73 μg/kg)
5 16 ± 2 53 ± 13
There were no significant between-group differences. Data are presented as
the mean ± standard deviation. aSex ratio (%) =male/(male + female) × 100.
Abbreviations: CB-NP carbon black nanoparticle
Onoda et al. Particle and Fibre Toxicology  (2017) 14:4 Page 8 of 16the high-dose group (73 μg/kg) was similar to that in
mice of a more advanced age (60-week-old) (Fig. 5b).
The detailed localization of Aqp4 was evaluated by
double-immunofluorescence staining (Aqp4 + GFAP)
and line profiling of fluorescence intensity in immuno-
stained brain sections. In the control group, Aqp4 im-
munofluorescence was localized proximal to blood
vessels (glia limitans region) and otherwise low in brain
tissue (parenchyma region > 5 μm from vessels)
(Fig. 5c,j,k). In the high-dose group, Aqp4 expression
was significantly (p < 0.05) increased in brain paren-
chyma region around blood vessels relative to the con-
trol group (Fig. 5f,j,k). GFAP expression was increased in
astrocyte end-feet around blood vessel in the cerebral
cortex of the high-dose group compared to the control
cortex (Fig. 5d,g). Aqp4 expression was most notably in-
creased in GFAP-positive astrocytes by maternal CB-NP
exposure (Fig. 5h).
Gene expression profiling by microarray and annotation
analyses
RNAs from the cerebral cortex were subjected to a micro-
array analysis to comprehensively investigate differences
in gene expression among the experimental groups. Of
62972 spots (28950 mRNAs) printed on the microarray,
30700 spots (22908 mRNAs) produced high-quality signalTable 3 Effect of maternal exposure to carbon black
nanoparticle on male offspring body weight
Group name Number of dams
(Number of offspring)
Age Body weight (g)
Control
(Ultra-pure water)
5 (18) 6 weeks 33 ± 2
Low-dose CB-NP
(2.9 μg/kg)
5 (18) 6 weeks 35 ± 3
Middle dose CB-NP
(15 μg/kg)
5 (19) 6 weeks 33 ± 2
High dose CB-NP
(73 μg/kg)
5 (20) 6 weeks 32 ± 1
There were no significant between-group differences. Data are presented as
the mean ± standard deviation. Abbreviations: CB-NP carbon black nanoparticleafter incubation with cerebral cortex samples. From these
30700 spots, 1168 spots (1126 mRNAs) exhibited up-
regulation > 2-fold or down-regulation < 0.5-fold in the
high-dose group relative to the control group. From these
1168 spots, 278 spots (268 mRNAs) were flagged with a
correlation coefficient (an index of dose-dependency) of >
0.7 or < −0.7. Functional analysis with GO revealed that
the 268 flagged mRNAs were significantly enriched in GO
terms related to blood vessels (angiogenesis, blood vessel
patterning, positive regulation of endothelial cell prolifera-
tion, vasculogenesis, blood vessel development, and ven-
tricular septum development), cell proliferation and
growth factors (positive regulation of cell migration, posi-
tive regulation of mesenchymal cell proliferation, growth
factor binding, and positive regulation of endothelial cell
proliferation), and chemotaxis/positive regulation of cell
migration (Table 4).
mRNAs from placenta tissues were also subjected to
microarray analysis. Of 62972 spots (28950 mRNAs)
printed on the microarray, 31781 spots (18269 mRNAs)
produced high-quality signal after incubation with pla-
centa samples. From these 31781 spots (18269 mRNAs),
817 spots (417 mRNAs) exhibited up-regulation > 2-fold
or down-regulation < 0.5-fold in the high-dose group
relative to the control group. From these 817 spots, 26
spots (19 mRNAs) were flagged with a correlation coeffi-
cient of > 0.7 or < −0.7. Functional analysis with GO re-
vealed that the flagged 19 mRNAs were not significantly
enriched in any GO terms.
qRT-PCR gene expression analysis of the cerebral cortex
RT-PCR was conducted in order to validate the micro-
array data and to obtain expression data for individual
samples. mRNA expression levels of Sox17, Tgfa, Flt1,
and Cyr61 in the cerebral cortex were significantly in-
creased in the high-dose group relative to the control
group (Sox17, Tgfa, and Cyr61: p < 0.05 vs. control; Flt1:
p < 0.01 vs. control). mRNA expression levels of Nos3,
Tbx1, and Kdr in cortices from offspring tended to in-
crease in a dose-dependent fashion following maternal
exposure to CB-NP (Fig. 6), but these changes were
non-significant.
Discussion
Quantitative dose–response analyses are critical compo-
nents of toxicological science [10]. However, no study to
date has evaluated the dose–response relationship of de-
velopmental neurotoxicity in offspring after maternal ex-
posure to NPs [7–9]. This literature deficit may be in
part due to a lack of previously established biomolecules
or behavioral parameters for use in quantitative dose–re-
sponse analyses. In the present study, we found that ma-
ternal CB-NP exposure dose-dependently increase
cortical GFAP expression in offspring mice, particularly
Fig. 4 (See legend on next page.)
Onoda et al. Particle and Fibre Toxicology  (2017) 14:4 Page 9 of 16
(See figure on previous page.)
Fig. 4 Expression level of glial fibrillary acidic protein (GFAP) in the cerebral cortices of offspring. a, b Quantification of GFAP protein expression in the
cerebral cortices of offspring by Western blotting. A one-way ANOVA showed a significant effect of CB-NP treatment (F3, 16 = 17.46, p< 0.001). Post hoc
Dunnett tests showed that GFAP protein expression was significantly (**p< 0.01) increased in the middle-dose and high-dose groups. c-m) Light
micrographs of GFAP-positive astrocytes in the cerebral cortices of offspring. Scale bars represent 100 μm (c, e, h, k), 50 μm (d, f, i, l),
and 10 μm (g, j, m), respectively. Cortices from 6-week-old male mice in the high-dose (k-m), middle-dose (g-j), and low-dose (e, f)
groups (e, f) and control group (c, d) are shown. d, f, i, l) Enlarged views of panels c, e, h, and k. j, m Enlarged views of panels i and l.
g Enlarged view of panel j. Arrows indicate enlarged PAS-positive granules. Data are presented as the mean ± standard deviation. Abbreviations: GFAP,
glial fibrillary acidic protein; NC, negative control; Olf, olfactory bulb; Cx, cerebral cortex; cc, corpus callosum; Str, striatum
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phages with PAS-positive enlarged lysosomal granules.
Maternal CB-NP exposure also dose-dependently in-
creased cortical Aqp4 expression in offspring mice, par-
ticularly in GFAP-positive astrocytes in the brain
parenchyma region around blood vessel. This is there-
fore the first study to report a quantitative dose–re-
sponse relationship between maternal exposure to NPs
and phenotypic changes in the central nervous system of
offspring mice. Moreover, our findings indicate that cor-
tical GFAP and Aqp4 are useful quantitative endpoints
for assaying NP-related developmental neurotoxicity.
The use of astrocytic GFAP and Aqp4 as toxicological
endpoints also provide information on the molecular
and cellular effects of NPs developmental neurotoxicity.
Astrocytes in the cerebral cortex (protoplasmic astro-
cytes) extend end-feet to neighboring blood vessels to
participate in the formation and maintenance of the
blood–brain barrier [23]. In other words, astrocytes form
a first line of brain defense by regulating blood–brain
barrier function [24, 25]. GFAP is an important marker
of astrocyte activation [26, 27] and reactive astrogliosis
in response to brain injury [28–30], and astrogliosis fa-
cilitates the reconstruction of the blood–brain barrier
and tissue remodeling local to sites of injury [31, 32]. In-
creases in astrocytic GFAP expression are frequently ac-
companied by increases in Aqp4 expression [33, 34].
Aqp4 is a water-selective channel that is highly
expressed in the perivascular membrane of astrocytic
end-feet in the central nervous system [14]. Accordingly,
Aqp4 plays important roles in regulating the flow of
brain fluids, ion homeostasis, and astrocyte plasticity in
response to a variety of injuries [14]. Furthermore, previ-
ous studies have indicated that increases in Aqp4 ex-
pression are associated with blood brain barrier leakage,
astrogliosis, and microglial activation in the context of
brain injury [33, 34]. Taken together, increased GFAP
and Aqp4 expression in the present study suggests that
maternal CB-NP exposure may have induced chronic
astrocyte activation, reactive gliosis, and blood brain bar-
rier leakage in developing offspring.
Changes in the expression profiles of GFAP and Aqp4
in offspring after maternal CB-NP exposure were similar
to those in observed in mice of a more advanced age.Many previous studies have shown that diffuse react-
ive astrogliosis is a general feature of the aging brain
[18, 35, 36]. Indeed, age-related increases in astrocytic
GFAP and Aqp4 expression have been observed in the
central nervous system [21, 22]. Moreover, astrocyte activa-
tion and an increase in GFAP are also observed in age-
related neurodegenerative disease such as dementia in-
cluding Alzheimer’s disease [23]. The increase in Aqp4
expression level is observed in the brain parenchyma re-
gion in normally aged mice [18], whereas acute insults
such as cerebral ischemia elevate Aqp4 expression level
in the astrocytic-endfeet on glial limitans [37–39]. To
this end, it is notable that alterations in Aqp4 regulate
the exchange of cerebrospinal fluid and interstitial fluid
(the glymphatic system) to affect the clearance of waste
including amyloid β [40, 41], and that the age-related
dysregulation of Aqp4 expression impairs this waste
clearance function [18]. In the present study, maternal
exposure to NPs had similar effects to that of aging and
accordingly, it can be speculated that these changes
might predispose offspring to age-related brain disor-
ders. In agreement with this speculation, a recent cohort
study of air pollution suggested that long-term exposure
to ambient fine particles promoted the effects of aging
in the brain [42]. Further investigations of the effects of
NPs on astrocytes can improve our understanding of the
effects, mechanisms, and repercussions of particulate
neurotoxicity.
The present study also examined the effects of mater-
nal CB-NP exposure on gene expression in the brains of
offspring and in placentae. Comprehensive alterations in
cortical mRNA expression were associated with angio-
genesis, cell migration, proliferation, chemotaxis, and
growth factor dysregulation in offspring. Another study
of CB-NP toxicity using intratracheal instillation also
show significant alterations of expression levels of
mRNA related to chemotaxis, inflammation, and cell
cycle in liver of offspring by comprehensive gene expres-
sion analysis [43]. In particular, Sox17, Tgfa, Flt1, and
Cyr61 were dose-dependently increased by maternal CB-
NP exposure and may be potential key molecules regu-
lating the histopathological changes of perivascular re-
gions induced by NP-associated neurotoxicity because
these genes are related to regulation of the homeostasis
Fig. 5 (See legend on next page.)
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Fig. 5 Expression level of aquaporin-4 (Aqp4) protein in the cerebral cortices of offspring. a, b Quantification of Aqp4 protein in the cerebral cortices
of offspring by western blotting. A one-way ANOVA showed a significant effect of CB-NP treatment (F3, 16 = 6.95, p < 0.01). Post hoc Dunnett tests
showed that Aqp4 protein expression was significantly (*p < 0.05) increased in the high-dose group. c-k Fluorescent micrographs of Aqp4 and glial
fibrillary acidic protein (GFAP) expression in the cerebral cortices of 6-week-old offspring and mice of a more advanced age (60-week-old). All scale bars
represent 80 μm. The cerebral cortices of 6-week-old male mice from the control (c-e) and high-dose (f-h) groups are shown. i Cerebral cortices of
60-week-old male mice as a positive control. c, f Aqp4; d, g GFAP; e, h, imerge of Aqp4 (red), GFAP (green), and nuclear stain (blue). j, k Quantification of Aqp4
immunofluorescence in linear regions placed over cerebral blood vessels (orange line on c and light blue line on f). *p<0.05, unpaired t-test. Data are presented
as the mean± SD. Abbreviations: Aqp4, aquaporin-4; GFAP, glial fibrillary acidic protein; NC, negative control
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[44–47]. Maternal inhalation of titanium dioxide NP
also lead to significant fetal microvascular dysfunc-
tion [48]. The published evidence and the data from
the present study indicate that the denaturation of
vascular development in the fetus is important for
understanding the developmental toxicity of the
nanoparticles. Of note, astrocytes surrounding blood ves-
sels play crucial roles in growth factor regulation, angio-
genesis, cell migration, and proliferation [49, 50]. Thus,
the dysregulation of these processes might be related to
chronic perivascular damage induced by maternal CB-NP
exposure in the brain. In particular, angiogenesis in the
cerebral cortex is disrupted by excessive neural stimula-
tion in the postnatal period [51]. It can be hypothesized
that maternal exposure to CB-NP perturbed neural activ-
ity in developing offspring during the postnatal period;
however, no direct evidence exists in support of this hy-
pothesis. Further investigation is required to clarify the
potential effects of maternal exposure to NPs on neuronal
activity, and the contribution of these effects to behavioralTable 4 Significantly enriched gene ontology categories according
Gene ontology Enrichment factor
Angiogenesis 3.66
Positive regulation of mesenchymal cell proliferation 10.11
positive regulation of epithelial cell proliferation 6.64
Growth factor binding 9.5
Patterning of blood vessels 8.47
Ventricular septum development 14.7
Chemotaxis 4.56
Positive regulation of endothelial cell proliferation 5.7
Vasculogenesis 5.7
Blood vessel development 5.41
Positive regulation of cell-substrate adhesion 7.13
Positive regulation of cell migration 3.36
Expression levels of 268 mRNAs were altered in a dose-dependent fashion in the hi
mRNAs were extracted using gene annotation by gene ontology (enrichment facto
ontology were defined as (nf/n)/(Nf/N), where nf is the number of flagged (differen
within that same category, n is the number of flagged genes on the entire microarrand histopathological changes during the postnatal devel-
opment of offspring.
Of note, while the present study demonstrated effects
of maternal CB-NP exposure in the cerebral cortices of
offspring mice, similar effects may have been diffusely
distributed throughout various other brain regions. A
previous study indicated that maternal airway exposure
to CB-NP caused diffuse and subchronic perivascular
abnormalities in the brains of offspring [13]; in particu-
lar, lysosomal granule enlargement and honeycomb-like
ultrastructure were observed in perivascular macro-
phages, which play a part in blood–brain barrier func-
tion to protect the brain against circulating foreign
matter and pathogen and to remove waste flowing from
the central nervous system into the cerebrospinal fluid
[52, 53], consistent with the present study. Diffuse histo-
pathological abnormalities related to the maternal en-
vironment may be important for understanding the
effects of maternal exposure on the risk of developing
a brain disorder, and warrant further investigation in
future studies.to cerebral cortex microarray data
P-value Gene symbol up-regulation Gene symbol
down-regulation
<0.001 Flt1, Kdr, Nos3, Ptprb, Robo4, Sox17,
Tbx1, Tgfa, Tie1
<0.001 Foxf1, Foxp2, Kdr, Tbx1
<0.001 Erbb2, Foxp2, Kdr, Tbx1, Tgfa
<0.001 Cyr61, Erbb2, Flt1, Kdr
0.001 Cxcl12, Flt1, Lef1, Tbx1
0.001 Cyr61, Luzp1, Stra6
0.005 Ccr3, Cmtm2b, Cxcl12, Cyr61, Flt1
0.005 Ccr3, Cxcl12, Kdr, Rptor
0.005 Foxf1, Kdr, Sox17, Tie1
0.006 Foxf1, Stra6, Tbx1, Tie1
0.008 Cyr61, Foxf1, Nid1
0.009 Cxcl12, Cyr61, Kdr, Lef1, Flt1, Foxf1
gh dose group versus the control group. Functional features of these 268
r ≥ 2, p value ≤ 0.01, symbol number ≥ 3). Enrichment factors for each Gene
tially expressed) genes within a given category, Nf is the total number of genes
ay, and N is the total number of genes on the microarray
Fig. 6 Expression levels of mRNA in the cerebral cortices of offspring. Expression levels of mRNA selected from microarray data and the gene
annotation analysis were analyzed by quantitative reverse transcription-polymerase chain reaction. Relative expression levels of the target genes
were calculated for each sample after normalization against Gapdh. A one-way ANOVA followed by post hoc Dunnett tests revealed significant
increases in Flt1 (a), Sox17 (d), Tgfa (f), and Cyr61 (h) gene expression in the cerebral cortices of high-dose group offspring compared to the control
group. *p < 0.05, **p < 0.01 vs. control. Kdr (b), Nos3 (c), and Tbx1 (e) showed non-significant increases in gene expression in the cerebral cortices of
high-dose group offspring compared to the control group. Up-regulation of Tie1 (g) and Cxcl12 (i) gene expression was not observed in each groups
Onoda et al. Particle and Fibre Toxicology  (2017) 14:4 Page 13 of 16In contrast to our above results, dysregulated genes in
the placenta did not populate a specific GO term in our
annotation analysis. Epidemiological studies have shown
that maternal exposure to ambient fine particles such as
PM2.5 and diesel exhaust particles is associated with fetal
malnutrition and low birth weight [54, 55], potentially
related to placental impairment [56–58]. In fact, mater-
nal exposure to diluted diesel exhaust rich in NP induce
disturbance of placental functions including placental
vascularization [59]. In the present study, we did not
find evidence for placental impairment, for abnormalitiesin offspring birth weights, or for functionally significant
mRNA dysregulation in the placenta after maternal
CB-NP exposure; this may have been due to the use of
CB-NP at relatively low doses in our study (2.9, 15, and
73 μg/kg). Moreover, the placental response to external
stimulus is actually different between male and female in
fetus [60, 61]. Therefore, the analysis considering the dif-
ference of sexes will elucidate the effects of maternal
CB-NP exposure on placenta in more detail.
The kinetics of NPs are important for understanding
the mechanisms underlying the effects of NP exposure.
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biological barriers in mammals including the blood-air
barrier [62–64] and the blood-placental barrier [65].
Moreover, NPs are transferred from the dam to the fetal
brain and liver [66] and can be detected in the brains of
offspring mice even after birth [67]. Therefore, it is pos-
sible that NPs directly led to adverse effects on develop-
ment through maternal exposure in the present study;
however, CB-NP may not translocate to the astrocytes
surrounding blood vessels in the brain. Again, this may
have been due to the relatively low doses of CB-NP used
in our study. Indeed, a previous study also failed to de-
tect CB-NP using transmission electron microscope in
perivascular macrophages or astrocytes of offspring from
mothers intranasally exposed to CB-NP (95 μg/kg) [13].
Therefore, it is also important to consider the indirect
effects of NP exposure on the fetus such as inflamma-
tion and oxidative stress in the dam [12, 68], as these
mechanisms may have also led to developmental neuro-
toxicity in the present study.
Finally, the exposure dose of CB-NP in the present
study and in the real world merits discussion. The con-
centration of CB-NP workers in carbon factories are
potentially exposed to has been estimated at up to
14 mg/m3 [69]. Predicted pulmonary deposition of CB-
NP aerosolisation based on observed particle size distri-
bution is estimated to be 35% [12]. Given that the daily
respiratory volume of a woman of 50 kg is approxi-
mately 15 m3, the amount of CB-NP female workers are
exposed to by inhalation is approximately 24 mg/8-h,
assuming that 35% particle deposit in the respiratory or-
gans. 24 mg CB-NP/50 kg/8 h/day corresponds to
480 μg CB-NP/kg/day. In the present study, the high-
dose group was exposed to a concentration of 73 μg
CB-NP/kg/day. Thus, the doses used in the present
study are highly relevant for an occupational setting. In
addition, the doses used in the present study are also
lower than doses used in other studies of CB-NP toxicity
using intratracheal instillation [43]. Although the dose
rate of intranasal administration, an experimental model
of pulmonary exposure in rodents, is temporarily higher
than the dose rate of inhalation of an aerosol, we believe
that our approach adds valuable insights to the field for
two reasons: (1) The dose of CB-NP used in the present
study is lower than the dose used for inhalation expos-
ure in a previous study (42 mg/m3, 1 h/day, 11 days)
[12] and (2) The dose of CB-NP employed in the current
study approximates the estimated dose for workers in
carbon factories. Nevertheless, further investigations of
the effects of maternal inhalation of NP on astrocytes in
the offspring brain are needed to allow for a comprehen-
sive risk assessment and to further our understanding of
the developmental neurotoxicity of maternal NP
exposure.Conclusions
The present study showed dose-dependent and long-
term induction of maternal CB-NP exposure on astro-
cyte activation and reactive astrogliosis in the cerebral
cortices of offspring mice. The astrocyte activation by
maternal CB-NP exposure was similar to those in ob-
served in mice of a more advanced age. Astrocytic GFAP
and Aqp4 expression may play key roles in the mecha-
nisms underlying NP-related developmental neurotox-
icity, and can accordingly serve as quantitative and
sensitive endpoints for the prediction of NP-associated
toxicities in future studies. Moreover, maternal CB-NP
exposure dysregulated mRNAs associated with angio-
genesis, cell migration, proliferation, chemotaxis, and
growth factor production including Sox17, Tgfa, Flt1,
and Cyr61 in the brains of offspring mice. The present
data will aid future investigations examining the features
and mechanisms of NP-associated developmental neuro-
toxicity, and moreover contribute to the establishment
of protective strategies against occupational and unin-
tended NP exposure.
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